SCHEMBL27404178

SCHEMBL27404178

Cc1nc2c(nc1C)-c1ccccc1C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
MAPT P10636 4/20 0.50
PKM P14618 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
ALDH1A1 P00352 3/20 0.50
RAB9A P51151 2/20 0.50
METAP2 P50579 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
TP53 P04637 3/20 0.43
CYP3A4 P08684 3/20 0.43
CYP2D6 P10635 3/20 0.43
CYP2C9 P11712 3/20 0.43
TSHR P16473 3/20 0.43
MAPK1 P28482 3/20 0.43
CYP2C19 P33261 3/20 0.43
HSD17B10 Q99714 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5799814 0.86 METAP2 (0.59) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL20348049 0.84 ADORA1 (0.49) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL20348039 0.84 ADORA1 (0.49) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL24704424 0.79 KDM4E (0.60) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL4071777 0.78 MAPT (0.65) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL24704131 0.75 MAPT (0.53) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL25983050 0.74 KDM4E (0.57) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL29493042 0.74 USP8 (0.50) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL25983052 0.74 KDM4E (0.41) KDM4EMAPTPKMSMN1; SMN2ALDH1A1
SCHEMBL26153067 0.74 ADORA1 (0.49) KDM4EMAPTPKMSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030890-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12018037-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018037-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound ORC3, LEF1, OCIAD1 KDM4E 2493/4885MAPT 1206/4885PKM 1207/4885
US-12030890-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures DDT, ESD, DBF4 KDM4E 1004/4885MAPT 3216/4885PKM 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.